ReWalk Robotics Ltd. (RWLK)
After hours:
| Previous close | 0.8437 |
| Open | 0.8300 |
| Bid | 0.8482 x 800 |
| Ask | 0.8482 x 1800 |
| Day's range | 0.8277 - 0.8501 |
| 52-week range | 0.7000 - 1.2300 |
| Volume | |
| Avg. volume | 243,834 |
| Market cap | 52.375M |
| Beta (5Y monthly) | 2.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
“Modern Miracles”: ReWalk Technology Showcased at the Hanukkah Celebration Hosted by the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp
ReWalk Robotics, Ltd. is honored to have presented its technology at the prestigious Modern Miracles Celebration with the Embassy of the State of Israel to Belgium and Luxembourg in Antwerp. Her Excellency Idit Rosenzweig Abu, Ambassador of Israel to Belgium, and Mr. Jacques Depuydt Her Excellency Idit Rosenzweig Abu, Ambassador of Israel to Belgium, and Mr. Jacques Depuydt, the first ReWalker in Belgium Her Excellency Idit Rosenzweig Abu, Ambassador of Israel to Belgium, and Mr. Jacques Depuydt
- GlobeNewswire
ReWalk Announces Extension of Share Repurchase Program
Reflects Confidence in Long-Term Potential of ReWalkMARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Dec. 22, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (the “Company” or “ReWalk”), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that its Board of Directors (the “Board”) has approved an extension of the current program to repurchase the Company’s Ordinary Shares, par value NIS 0.25 per share, with such ex
- GlobeNewswire
Germany’s second largest health insurer withdraws appeal with Federal Social Court, accepts prior ruling of exoskeletons as direct disability compensation
Precedent set for all future cases as State Court verdict is legally binding and enforceable Following the outcome of this legal dispute, eligible paraplegics in Germany have an easier pathway to be provided with a ReWalk exoskeleton going forward MARLBOROUGH, Mass. and BERLIN, Nov. 11, 2022 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), today welcomed the decision by BARMER to accept the prior ruling from the state court that exoskeletons are considered as
